Evolving therapies for myocardial ischemia/reperfusion injury.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the American College of Cardiology

• Publication date

  2015-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2015.02.032PMID 25857912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial.

  2015cited by this paper
• Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction.

  2015cited by this paper
• Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization.

  2015cited by this paper
• Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.

  2015cited by this paper
• CAESAR: one step beyond in the construction of a translational bridge for cardioprotection.

  2015cited by this paper
• Remote ischemic conditioning.

  2015cited by this paper
• Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.

  2015cited by this paper
• The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.

  2015cited by this paper
• ST–Segment-Elevation Myocardial Infarction Patients Randomized to a Pharmaco-Invasive Strategy or Primary Percutaneous Coronary Intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-Year Mortality Follow-Up

  2014cited by this paper
• Autophagy gene fingerprint in human ischemia and reperfusion.

  2014cited by this paper
• Block the ischemia and reperfusion damage: an old adjunctive drug for a new reperfusion strategy.

  2014cited by this paper
• Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning

  2014cited by this paper
• STEMI Patients Randomized to a Pharmaco-Invasive Strategy or Primary PCI: The STREAM 1-Year Mortality Follow-Up

  2014cited by this paper
• 272Pre-reperfusion metoprolol administration reduces ischemia/reperfusion injury (IRI) through beta1-adrenergic receptor (b1AR) blockade in the circulating cells

  2014cited by this paper
• Cardiovascular remodelling in coronary artery disease and heart failure.

  2014cited by this paper
• Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).

  2014cited by this paper
• Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction.

  2014cited by this paper
• Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PC

  2014cited by this paper
• No Evidence for Activated Autophagy in Left Ventricular Myocardium at Early Reperfusion with Protection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting

  2014cited by this paper
• CMR assessment of microvascular obstruction in STEMI: ready for prime time?

  2014cited by this paper
• Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Channel Formation by Yeast F-ATP Synthase and the Role of Dimerization in the Mitochondrial Permeability Transition*♦

  2014cited by this paper
• The history of coronary reperfusion.

  2014cited by this paper
• Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.

  2014cited by this paper
• Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.

  2014cited by this paper
• Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)

  2014cited by this paper
• Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.

  2014cited by this paper
• Do current clinical trials meet society's needs?: a critical review of recent evidence.

  2014cited by this paper
• SnapShot: Necroptosis.

  2014cited by this paper
• Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies.

  2014cited by this paper
• Postconditioning attenuates no-reflow in STEMI patients

  2013cited by this paper
• Cardioprotection: chances and challenges of its translation to the clinic.

  2013cited by this paper
• Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning.

  2013cited by this paper
• The human coronary collateral circulation: development and clinical importance.

  2013cited by this paper
• Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.

  2013cited by this paper
• Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: The Effects of Postconditioning on Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (POST) Randomized Trial

  2013cited by this paper
• Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

  2013cited by this paper
• Door-to-balloon time and mortality among patients undergoing primary PCI.

  2013cited by this paper
• Cell death in the myocardium: My heart won't go on

  2013cited by this paper
• Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris.

  2013cited by this paper
• Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Current State of Clinical Translation of Cardioprotective Agents for Acute Myocardial Infarction

  2013cited by this paper
• Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.

  2013cited by this paper
• Peri-interventional coronary vasomotion.

  2012cited by this paper
• Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.

  2012cited by this paper
• Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction.

  2012cited by this paper
• Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

  2012cited by this paper
• Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis

  2012cited by this paper
• The coronary circulation in cardioprotection: more than just one confounder.

  2012cited by this paper
• Contribution of calpains to myocardial ischaemia/reperfusion injury.

  2012cited by this paper
• Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.

  2012cited by this paper
• Therapeutic hypothermia for acute myocardial infarction and cardiac arrest.

  2012cited by this paper
• Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction.

  2012cited by this paper
• Defining Heart Failure End Points in ST-Segment Elevation Myocardial Infarction Trials: Integrating Past Experiences to Chart a Path Forward

  2012cited by this paper
• Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury.

  2012cited by this paper
• Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase

  2011cited by this paper
• Circadian variations of infarct size in acute myocardial infarction

  2011cited by this paper
• Extent of and Reasons for Nonuse of Implantable Cardioverter Defibrillator Devices in Clinical Practice Among Eligible Patients With Left Ventricular Systolic Dysfunction

  2011cited by this paper
• Cardiomyocyte death: mechanisms and translational implications

  2011cited by this paper
• Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation

  2011cited by this paper
• Preconditioning Involves Selective Mitophagy Mediated by Parkin and p62/SQSTM1

  2011cited by this paper
• Acute induction of autophagy as a novel strategy for cardioprotection

  2011cited by this paper
• High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.

  2011cited by this paper
• The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion.

  2011cited by this paper
• Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance.

  2010cited by this paper
• Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

  2010cited by this paper
• Profound Cardioprotection With Chloramphenicol Succinate in the Swine Model of Myocardial Ischemia-Reperfusion Injury

  2010cited by this paper
• Microvascular thrombosis: an exciting but elusive therapeutic target in reperfused acute myocardial infarction.

  2010cited by this paper
• Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction

  2010cited by this paper
• Review: Autophagy: Definition, Molecular Machinery, and Potential Role in Myocardial Ischemia-Reperfusion Injury

  2010cited by this paper
• Microvascular obstruction: underlying pathophysiology and clinical diagnosis.

  2010cited by this paper
• TNFα in myocardial ischemia/reperfusion, remodeling and heart failure

  2010cited by this paper
• Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

  2010cited by this paper
• Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection

  2010cited by this paper
• Myocardial no-reflow in humans.

  2009cited by this paper
• The mitochondrial permeability transition pore and ischemia-reperfusion injury

  2009cited by this paper
• Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning

  2009cited by this paper
• Coronary microembolization: from bedside to bench and back to bedside.

  2009cited by this paper
• Pathophysiology of Myocardial Infarction

  2008cited by this paper
• Effect of cyclosporine on reperfusion injury in acute myocardial infarction.

  2008cited by this paper
• Impact of Ischemia and Reperfusion Times on Myocardial Infarct Size in Mice In Vivo

  2008cited by this paper
• Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

  2008cited by this paper
• Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging.

  2007cited by this paper
• Cardiac effects of postconditioning depend critically on the duration of index ischemia.

  2007cited by this paper
• Myocardial reperfusion injury.

  2007cited by this paper
• Preconditioning and postconditioning: united at reperfusion.

  2007cited by this paper
• Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage: Analysis of Ischemic Myocardium at Risk Using Cardiac Magnetic Resonance

  2007cited by this paper
• Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

  2005cited by this paper
• Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Myocardial hibernation: a delicate balance.

  2005cited by this paper
• Postconditioning the Human Heart

  2005cited by this paper
• Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial

  2005cited by this paper
• Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

  2005cited by this paper
• The first minutes of reperfusion: a window of opportunity for cardioprotection.

  2004cited by this paper
• Ischemic preconditioning and preinfarction angina in the clinical arena

  2004cited by this paper
• Postconditioning: old wine in a new bottle?

  2004cited by this paper

• Exercise training reinforces the therapeutic efficacy of bone marrow-derived mesenchymal stem cell transplantation for ventricular ectopy and myocardial infarction injury

  2026cites this paper
• Therapeutic interventions for coronary microvascular obstruction after acute myocardial infarction: Developments and challenges.

  2026cites this paper
• Hypoxia, ROS, and HIF Signaling in I/R Injury: Implications and Future Prospects.

  2026cites this paper
• METTL1‐Mediated N7‐Methylguanosine tRNA Modification Alleviates Cardiac Ischemia/Reperfusion Injury by Modulating Mitochondrial Energy Metabolism

  2026cites this paper
• Potential cardioprotective and regenerative effects of the fluorinated benzothiazole derivative AS09 in the myocardial infarction-induced zebrafish.

  2026cites this paper
• The Potential Protective Effect of Carvedilol on Induced Myocardial Ischemia-Reperfusion Injury in Rats: A Histological and Immunohistochemical Study.

  2026cites this paper
• Reading the Signature of Autophagy in the Ischemic and Infarcted Heart: A Systematic Review of Circulating Biomarkers

  2026cites this paper
• Medicinal Plants and Phytochemicals in Cardioprotection—Mechanistic Pathways and Translational Roadmap

  2026cites this paper
• Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway

  2026cites this paper
• Heart-on-a-chip and vasculature-on-a-chip platforms as models of cardiovascular disease.

  2026cites this paper
• Ferulic acid in combination with ginsenoside Rb1 alleviates myocardial no-reflow by inhibiting platelet HMGB1 release and NET formation

  2026cites this paper
• HIF-1 signaling in myocardial infarction: Gene regulatory networks, cellular adaptation, and emerging therapeutic directions

  2026cites this paper
• TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn2+ Homeostasis.

  2026cites this paper
• PAF Triggered Pyroptotic NETosis Aggravates Myocardial Ischemia/Reperfusion Injury.

  2026cites this paper
• β-Sitosterol suppresses NLRP3 Inflammasome activation and Pyroptosis in myocardial ischemia/reperfusion injury via inhibition of PPARγ2.

  2025cites this paper
• 3,4‐Dimethoxychalcone alleviates limb ischemia/reperfusion injury by TFEB‐mediated autophagy enhancement and antioxidative response

  2025cites this paper
• Temporal profiling of myocardial inflammation and recovery in a murine model of cardiac arrest and adrenaline exposure

  2025cites this paper
• Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1N532/M550 and promoting its degradation

  2025cites this paper
• A novel lactylation-related gene signature for diagnostic and therapeutic insights in acute myocardial infarction

  2025cites this paper
• Apelin13 Loaded Nano-Niosomes Confer Cardioprotection in a Rat Model of Myocardial Ischemia Reperfusion by Targeting the Nrf2/HO-1 Pathway

  2025cites this paper
• Lights-on for Cardiovascular Disease: Can Red and Near Infrared Light Treatment Help the Recovery Process?

  2025cites this paper
• Targeting a specific subset of neutrophils to mitigate cardiac reperfusion injury

  2025cites this paper
• Mechanism of Qilong Capsule against Myocardial Ischemia-Reperfusion Injury Based on Network Pharmacology and Experimental Validation.

  2025cites this paper
• Puerarin pretreatment provides protection against myocardial ischemia/reperfusion injury via inhibiting excessive autophagy and apoptosis by modulation of HES1

  2025cites this paper
• Impact of different glycoprotein IIb/IIIa inhibitor infusion routes on infarct size and microvascular obstruction in patients with high thrombotic risk ST elevation myocardial infarction

  2025cites this paper
• Serpina3k lactylation protects from cardiac ischemia reperfusion injury

  2025cites this paper
• Roles and mechanisms of ginsenoside Rg1 in coronary artery disease: Progress and perspectives

  2025cites this paper
• Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment

  2025cites this paper
• Infarct‐Related Myocardial Resistance Before Reperfusion in Patients With Acute Myocardial Infarction to Predict Microvascular Injury and Clinical Outcomes

  2025cites this paper
• Huanglian Jiedu Decoction Alleviates Myocardial Ischemia-Reperfusion Injury via AKT-Mediated Regulation of Endoplasmic Reticulum Stress

  2025cites this paper
• Characterization of Infarct Size and Remodeling Using CMR and PET in Mice Models of Reperfused and Non-Reperfused Myocardial Infarction

  2025cites this paper
• RNF5-mediated ubiquitination of ACSL4 attenuates ferroptosis and confers cardioprotection against myocardial ischemia/reperfusion injury.

  2025cites this paper
• Temporal regulation of genetic programs governing multiple cell death during myocardial ischemia-reperfusion injury

  2025cites this paper
• Interleukin-6 induces upregulation of BNIP3 in cardiomyocytes to protect against myocardial ischemia/reperfusion injury.

  2025cites this paper
• A systematic review on polysaccharides from Ophiopogonis Radix and Liriopes Radix: Advances in the preparation, structural characterization and pharmacological activities.

  2025cites this paper
• HMC ameliorates myocardial ischaemia–reperfusion injury through suppressing cuproptosis via the de‐ubiquitination and stabilization of ATP7A

  2025cites this paper
• Safety and Sufficient Cardiac Rehabilitation With a Wearable Activity Tracker in a Patient With Acute Myocardial Infarction and Residual Stenosis

  2025cites this paper
• Research progress on programmed cell death of cardiomyocytes in pressure-overload hypertrophic cardiomyopathy

  2025cites this paper
• Cardiac Ischaemia–Reperfusion Injury: Pathophysiology, Therapeutic Targets and Future Interventions

  2025cites this paper
• Temporal and Spatial Dynamics in the Regulation of Myocardial Metabolism During the Ischemia-Reperfusion Process

  2025cites this paper
• Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: rationale and design of the EMPA-PCI trial

  2025cites this paper
• Cardioprotective Effects of Apelin in Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction

  2025cites this paper
• Myocardial stunning: mechanisms, molecular insights, and gaps in knowledge

  2025cites this paper
• Xanthosine alleviates myocardial ischemia–reperfusion injury through attenuation of cardiomyocyte ferroptosis

  2025cites this paper
• Role of annexin A7 in the occurrence and progression of coronary atherosclerosis: a narrative review

  2025cites this paper
• Assessment of infarct characteristics and left ventricular function on serial CMR in STEMI patients treated with post-PCI sonothrombolysis: post-hoc analysis of two randomized controlled trials

  2025cites this paper
• A brief history of circadian time in the heart.

  2025cites this paper
• Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies

  2025cites this paper
• Phillygenin ameliorates myocardial ischemia-reperfusion injury by inhibiting cuproptosis via the autophagy-lysosome degradation of CTR1.

  2025cites this paper
• Low doses of ozone alleviate cardiomyocyte ferroptosis induced by hypoxia–reoxygenation injury via the AMPK–mTOR pathway

  2025cites this paper
• Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study

  2025cites this paper
• Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies

  2025cites this paper
• ROS-differentiated release of Apelin-13 from hydrogel comprehensively treats myocardial ischemia-reperfusion injury.

  2025cites this paper
• Ultrafast ROS Scavenging Activity of Amur Maple Tree Extracts Confers Robust Cardioprotection for Myocardial Ischemia/Reperfusion Injury

  2025cites this paper
• Effects of inpatient and outpatient cardiac rehabilitation on the 5-year prognosis in patients with acute myocardial infarction.

  2025cites this paper
• Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024

  2025cites this paper
• Umbilical Cord Matrix (Wharton Jelly) Mesenchymal Stem Cells in Next-Generation Myocardial Repair and Regeneration: Mechanisms and Pre-Clinical Evidence.

  2025cites this paper
• A Spotlight on PLGA-Based Nanoparticles: Pioneering a New Era in the Therapeutics of Cardiovascular Disorders.

  2025cites this paper
• Exosomes derived from human umbilical cord mesenchymal stem cells can reverse ventricular remodeling and improve long-term cardiac function after acute myocardial infarction.

  2025cites this paper
• Progress of nanomaterials in the treatment of ischemic heart disease.

  2025cites this paper
• Cardioprotection method for percutaneous coronary interventions in elderly patients with acute coronary syndrome

  2025cites this paper
• The contribution of cardiomyocyte hypercontracture to the burden of acute myocardial infarction: an update

  2025cites this paper
• Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model

  2025cites this paper
• Microcirculatory dysfunction in patients with acute anterior myocardial infarction combined with new complete right bundle branch block

  2025cites this paper
• Myocardial mitochondrial antiviral signaling protein promotes heart Ischemia-reperfusion injury via RIG-I signaling in mice

  2025cites this paper
• Molecular Pathways and Therapeutic Advances in Ischemic Heart Diseases

  2025cites this paper
• Quercetin Alleviates the Inflammatory Response and Oxidative Stress of Myoblasts after Ischemia/Reperfusion by Inhibiting NOX-2

  2025cites this paper
• Intervention of natural products targeting novel mechanisms after myocardial infarction.

  2025cites this paper
• The Association of Plasma Osmolarity With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study

  2025cites this paper
• TSLP mitigates post-infarction myocardial remodeling by promoting eosinophil recruitment and inhibiting JAK1–STAT5-mediated ferroptosis

  2025cites this paper
• Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease

  2025cites this paper
• Wedelolactone attenuates myocardial ischemia/reperfusion injury through inhibition of ferroptosis via the METTL3/BRD4 axis.

  2025cites this paper
• Liposomal Delivery of Allolobophora caliginosa Coelomic Fluid Attenuates Myocardial Infarction by Suppressing Oxidative Damage, Inflammation, and Apoptosis

  2025cites this paper
• Attenuation of myocardial ischemia–reperfusion injury in mice through CD80/86 deficiency: improved microvascular obstruction via reduced macrophage and T lymphocyte infiltration

  2025cites this paper
• Tetramethylpyrazine protects against myocardial ischemia/reperfusion injury via regulating Myl2-mediated NLRP3 signaling pathway inhibition.

  2025cites this paper
• Evaluation of Myocardial Protection in Prolonged Aortic Cross-Clamp Times: Del Nido and HTK Cardioplegia in Adult Cardiac Surgery

  2025cites this paper
• Clinical study of Yiqi Liangxue Shengji prescription for improving cardiac function after myocardial ischemia reperfusion injury in patients with acute myocardial infarction: a randomized, double-blind, placebo-controlled trial.

  2025cites this paper
• From Brain to Lung: Emerging Insights into Mesenchymal Stem Cell-Derived Extracellular Vesicle-Associated Cargos in Ischemia-Reperfusion Injury

  2025cites this paper
• Mechanism of post cardiac arrest syndrome based on animal models of cardiac arrest

  2025cites this paper
• Robinin decreases myocardial ischemia/reperfusion injury via Nrf2 anti-oxidative effects mediated by Akt/GSK3β/Fyn in hypercholesterolemic rats

  2025cites this paper
• CD38 connects the heart and brain

  2025cites this paper
• Mechanism of LncRNA NORAD/MiR-144-3p Axis in Promoting Myocardial Ischemia-Reperfusion Injury by Targeting TNRC6A.

  2025cites this paper
• Myocardial Ischemia/Reperfusion Injury: Molecular Insights, Forensic Perspectives, and Therapeutic Horizons

  2025cites this paper
• Aucubin protects against myocardial ischemia-reperfusion injury by regulating STAT3/NF-κB/HMGB-1 pathway.

  2024cites this paper
• Oxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury

  2024cites this paper
• Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway.

  2024cites this paper
• Protein lysine acetylation does not contribute to the high rates of fatty acid oxidation seen in the post-ischemic heart

  2024cites this paper
• Protective role of kallistatin in oxygen-glucose deprivation and reoxygenation in human umbilical vein endothelial cells

  2024cites this paper
• Intramyocardial Hemorrhage Leads to Higher MACE Rate by Increasing Myocardial Infarction Volume in Patients with STEMI

  2024cites this paper
• Mitigation of myocardial ischemia/reperfusion-induced chronic heart failure via Shexiang Baoxin Pill-mediated regulation of the S1PR1 signaling pathway.

  2024cites this paper
• Triple Hybrid Cellular Nanovesicles Promote Cardiac Repair after Ischemic Reperfusion.

  2024cites this paper
• UPF1 Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating SMURF2-Mediated Ubiquitination Degradation of FOXA2

  2024cites this paper
• Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• Fibrin-targeted phase shift microbubbles for the treatment of microvascular obstruction

  2024cites this paper
• Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study.

  2024cites this paper
• Identification of VDAC1 as a cardioprotective target of Ginkgolide B.

  2024cites this paper
• Understanding integrative approach of translational bioinformatics on cardiovascular disease: Myocardial Ischemia

  2024cites this paper
• Puerarin Protects Myocardium From Ischaemia/Reperfusion Injury by Inhibiting Ferroptosis Through Downregulation of VDAC1

  2024cites this paper
• Impact of Mild Hypothermia As Adjunctive Therapy in Patients With ST‐Elevation Myocardial Infarction: A Meta‐Analysis and Trial Sequential Analysis of Randomized Controlled Trials

  2024cites this paper